About Royal Sense Limited
Data last updated:
Royal Sense Limited is a public limited company based in Delhi, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 06 April 2023.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN L46491DL2023PLC412051. It is a listed company as per MCA records. Its shares are listed on BSE: 544143.
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹5.35 Cr. It is led by directors including Rishabh Arora (Managing Director) and Harmeet Singh (Whole-Time Director).
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at C – 7, Phase – 3 Badli Industrial Area, Delhi, India – 110042.
As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹103.38 Cr, a growth of 67.5% compared to the previous year. For the same year it recorded a net profit of ₹7.15 Cr (net margin 6.9%) and EBITDA of ₹10.96 Cr (EBITDA margin 10.6%). The net worth stands at ₹40.5 Cr (up 46% YoY). Total assets are valued at ₹54.38 Cr (up 75% YoY).
The company is associated with 1 brand: Royal Sense. As per MCA filings, the company has open charges of ₹8.89 Cr and satisfied charges of ₹3.3 Cr on record. Court records list 9 cases involving the company, including 9 filed by the company; 9 cases are pending. The company has 9 deals on record (5 market trades, 2 secondary share transfers, 1 ipo), with disclosed funding of ₹3.44 Cr; the latest was in April 2024. Its 7 peer companies in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 3 larger and 4 smaller; the largest is Pioneer Medical Systems Private Limited with revenue of ₹63.38 Cr.
For more details, the company can be reached via its website royalsense.in.
Company details
CIN history
Royal Sense has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L46491DL2023PLC412051, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L46491DL2023PLC412051 | Current |
| U21006DL2023PLC412051 | Previous |
| L21006DL2023PLC412051 | Previous |
Contact details
Royal Sense Limited's registered office is in Delhi, Delhi.
- Registered AddressC – 7, Phase – 3 Badli Industrial Area, Delhi, India – 110042
- IndustryHealthcare, Medical Equipment Retail & Distribution
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Royal Sense operates one associated brand: Royal Sense. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provider of surgical supplies, tools, equipment, and other products | royalsense.in |
Business activity
The main business activity of Royal Sense is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Royal Sense Limited, buy the company report.
Financials of Royal Sense Limited
FY 2025-26 filings availableRoyal Sense Limited reported revenue of ₹103.38 Cr (up 67.5% YoY) for FY 2025-26.
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 |
|---|---|---|---|
| Revenue from Operations | ₹103.38 Cr | ₹61.73 Cr | ₹17.8 Cr |
| Other Income | ₹11 Lakh | ₹8 Lakh | ₹3 Lakh |
| Employee Benefit Expense | - | ₹1.48 Cr | ₹44 Lakh |
| Finance Costs | ₹1.06 Cr | ₹21 Lakh | ₹9 Lakh |
| Depreciation & Amortisation | ₹5 Lakh | ₹2 Lakh | ₹1 Lakh |
| Other Expenses | - | ₹1.7 Cr | ₹38 Lakh |
| Total Expenses | ₹92.42 Cr | ₹52.86 Cr | ₹15.53 Cr |
| Profit Before Tax | ₹9.96 Cr | ₹8.72 Cr | ₹2.2 Cr |
| Total Tax Expense | ₹2.81 Cr | ₹2.4 Cr | ₹61 Lakh |
| Net Profit | ₹7.15 Cr | ₹6.32 Cr | ₹1.59 Cr |
| EBITDA (computed) | ₹10.96 Cr | ₹8.87 Cr | ₹2.27 Cr |
| Basic EPS | ₹12.46 | ₹12.74 | ₹3.24 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 |
|---|---|---|---|
| Total Assets | ₹54.38 Cr | ₹31.08 Cr | ₹19.83 Cr |
| Current Assets | ₹57.42 Cr | ₹33.36 Cr | ₹20.18 Cr |
| Property, Plant & Equipment | ₹1.84 Cr | ₹1.65 Cr | ₹5 Lakh |
| Inventories | ₹14.42 Cr | ₹5.75 Cr | ₹4.15 Cr |
| Trade Receivables | ₹28.49 Cr | ₹14.56 Cr | ₹3.22 Cr |
| Cash & Equivalents | ₹2.92 Cr | ₹11.25 Cr | ₹8.74 Cr |
| Equity (Net Worth) | ₹40.5 Cr | ₹27.74 Cr | ₹18.22 Cr |
| Equity Share Capital | ₹5.35 Cr | ₹4.97 Cr | ₹4.9 Cr |
| Total Debt (computed) | ₹12.8 Cr | ₹3.26 Cr | ₹1.6 Cr |
| Current Liabilities | ₹6.73 Cr | ₹4.48 Cr | ₹95 Lakh |
| Total Liabilities | ₹54.38 Cr | ₹31.08 Cr | ₹19.83 Cr |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 |
|---|---|---|---|
| Operating Cash Flow | -₹13.29 Cr | ₹1.21 Cr | -₹3.87 Cr |
| Investing Cash Flow | -₹44 Lakh | -₹1.56 Cr | -₹52 Lakh |
| Financing Cash Flow | ₹5.4 Cr | ₹2.86 Cr | ₹13.13 Cr |
| Net Change in Cash | -₹8.33 Cr | ₹2.5 Cr | ₹8.74 Cr |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|---|
| Revenue from Operations | ₹37.75 Cr | ₹27.64 Cr | ₹18.96 Cr | ₹4.64 Cr |
| Other Income | ₹9 Lakh | ₹8 Lakh | ₹3 Lakh | ₹0 |
| Cost of Materials Consumed | - | ₹23.07 Cr | ₹15.98 Cr | ₹4.45 Cr |
| Employee Benefit Expense | - | ₹1.36 Cr | ₹44 Lakh | ₹10 Lakh |
| Finance Costs | ₹80 Lakh | ₹18 Lakh | ₹9 Lakh | ₹0 |
| Depreciation & Amortisation | ₹5 Lakh | ₹2 Lakh | ₹1 Lakh | ₹0 |
| Other Expenses | - | ₹1.6 Cr | ₹37 Lakh | ₹4 Lakh |
| Total Expenses | ₹32.93 Cr | ₹23.38 Cr | ₹16.59 Cr | ₹3.95 Cr |
| Profit Before Tax | ₹4.06 Cr | ₹4.14 Cr | ₹2.3 Cr | ₹69 Lakh |
| Total Tax Expense | ₹1.04 Cr | ₹1.08 Cr | ₹60 Lakh | ₹18 Lakh |
| Net Profit | ₹3.02 Cr | ₹3.06 Cr | ₹1.7 Cr | ₹51 Lakh |
| EBITDA (computed) | ₹4.82 Cr | ₹4.26 Cr | ₹2.37 Cr | ₹69 Lakh |
| Basic EPS | ₹5.25 | ₹6.13 | ₹3.47 | ₹5.87 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|---|
| Total Assets | ₹43.25 Cr | ₹27.9 Cr | ₹19.94 Cr | ₹4.43 Cr |
| Current Assets | ₹28.69 Cr | ₹15.09 Cr | ₹16.26 Cr | ₹5.59 Cr |
| Property, Plant & Equipment | ₹1.82 Cr | ₹1.65 Cr | ₹5 Lakh | ₹5 Lakh |
| Inventories | ₹7.24 Cr | ₹2.99 Cr | ₹27 Lakh | ₹1.3 Cr |
| Trade Receivables | ₹15.44 Cr | ₹8.92 Cr | ₹4.7 Cr | ₹1.28 Cr |
| Cash & Equivalents | ₹2.81 Cr | ₹1.38 Cr | ₹7.77 Cr | ₹40 Lakh |
| Equity (Net Worth) | ₹33.18 Cr | ₹24.57 Cr | ₹18.34 Cr | ₹4.15 Cr |
| Equity Share Capital | ₹5.35 Cr | ₹4.97 Cr | ₹4.9 Cr | ₹3.45 Cr |
| Total Debt (computed) | ₹8.99 Cr | ₹3.26 Cr | ₹1.6 Cr | ₹28 Lakh |
| Current Liabilities | ₹2.86 Cr | ₹2.94 Cr | ₹94 Lakh | ₹1.27 Cr |
| Total Liabilities | ₹43.25 Cr | ₹27.9 Cr | ₹19.94 Cr | ₹4.43 Cr |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|---|
| Operating Cash Flow | -₹3.58 Cr | ₹1.8 Cr | -₹79 Lakh | ₹40 Lakh |
| Investing Cash Flow | -₹65 Lakh | -₹11.07 Cr | -₹4.55 Cr | ₹0 |
| Financing Cash Flow | ₹5.66 Cr | ₹2.89 Cr | ₹13.1 Cr | ₹1 Lakh |
| Net Change in Cash | ₹1.43 Cr | -₹6.39 Cr | ₹7.77 Cr | ₹40 Lakh |
To see the full year-wise statements and ratios of Royal Sense Limited, buy the company report.
Board of directors of Royal Sense Limited
Royal Sense has 5 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rishabh Arora Also directs: Stergic Retail Private Limited, Royal Transvera Private Limited, TTG Innovations Private Limited and 1 more | Managing Director | 06 Apr 2023 | 3 Years 6 Months | Current |
| Harmeet Singh | Whole-Time Director | 06 Apr 2023 | 3 Years 6 Months | Current |
| Kajal Also directs: Rac Extrusions Limited | Director | 30 May 2024 | 2 Years 4 Months | Current |
| Heena Soni Also directs: Prefcom Capital Advisors Private Limited | Director | 30 May 2024 | 2 Years 4 Months | Current |
| Vikas Also directs: Stergic Retail Private Limited | Director | 04 Mar 2024 | 2 Years 7 Months | Current |
Peer comparison
Royal Sense Limited is compared with the 7 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Royal Sense Limitedthis company | ₹103.38 Cr (FY 2026) | ₹7.15 Cr | 6.9% | 67.5% | Delhi, India | |
| Pioneer Medical Systems Private Limited | ₹63.38 Cr (FY 2024) | 26.0% | Chennai, Tamil Nadu, India | |||
| Medline Healthcare Industries Private Limited | ₹62.32 Cr (FY 2025) | 16.0% | Pune, Maharashtra, India | |||
| Molnlycke Health Care India Private Limited | ₹62.27 Cr (FY 2025) | 7.0% | Gurgaon, Haryana, India | |||
| Satyam Synergy India Private Limited | ₹61.67 Cr (FY 2025) | 24.0% | Nabha, Punjab, India | |||
| Advanced Bionics India Private Limited | ₹61.36 Cr (FY 2025) | 2.0% | Bengaluru, Karnataka, India | |||
| RMC Medical Services Private Limited | ₹60.71 Cr (FY 2024) | 15.0% | Coimbatore, Tamil Nadu, India | |||
| Axess Medicom Private Limited | ₹60.57 Cr (FY 2025) | 27.0% | Bhubaneswar, Odisha, India |
To see the full peer comparison of Royal Sense Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Aug 2026 | 101380088 | Others | ₹1.4 Cr | Open | |
| 23 Oct 2025 | 101174251 | Others | ₹7.49 Cr | Open | |
| 28 Nov 2023 | 100834034 | Others | ₹3 Cr | Satisfied | |
| 26 May 2023 | 100735977 | Others | ₹30 Lakh | Satisfied |
To see the full charge records of Royal Sense Limited, buy the company report.
Total charge records: 4 View all charges
Deals & funding
Royal Sense Limited has 9 deals on record (5 market trades, 2 secondary share transfers, 1 ipo), with disclosed funding of ₹3.44 Cr; the latest was in April 2024.
Deals on record (5 of 9)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Apr 2024 | Market trade | ₹1.52 Cr | Buyer: Lathe Derivatives Trading Private Limited , Rikhav Securities Limited , an individual Seller: Rikhav Securities Limited , Lathe Derivatives Trading Private Limited |
| Mar 2024 | Market trade | ₹40.6 Lakh | Seller: Haryana Refractories Pvt Ltd |
| Mar 2024 | Market trade | ₹85.4 Lakh | Buyer: Rikhav Securities Limited , 2 individuals Seller: Rikhav Securities Limited |
| Mar 2024 | Market trade | ₹2.71 Cr | Buyer: RNR Wealth Management Private Limited , Supracure Pharma Private Limited , 2 individuals Seller: Manoj Agarwal (Huf), 2 individuals |
| Feb 2024 | Secondary share transfer | Undisclosed | Buyer: Haryana Refractories Pvt Ltd , 3 individuals Seller: an individual |
To see the full deal history of Royal Sense Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Royal Sense Limited has 9 court cases on record: 9 filed by Royal Sense. All cases are pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 9 | 0 | 9 |
Cases on record (5 of 9)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, North, Delhi | Cheque dishonour complaint | Filed by the company against an individual | Pending |
| District court, North, Delhi | Civil suit | Filed by the company against Global Medical Agency | Pending |
| District court, South, Delhi | Cheque dishonour complaint | Filed by the company against an individual | Pending |
| District court, South, Delhi | Cheque dishonour complaint | Filed by the company against an individual | Pending |
| District court, South, Delhi | Cheque dishonour complaint | Filed by the company against an individual | Pending |
To see the full case history of Royal Sense Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Royal Sense Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Royal Sense Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Royal Sense Limited has 16 board changes on record since 2023: 7 appointments and 9 cessations. The latest: Heena Soni ceased to be Additional Director on 22 Oct 2024.
15 earlier events are in the company report.
Frequently asked questions
Royal Sense is an active public limited company based in Delhi, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 06 April 2023 (3+ years old) and is registered under CIN L46491DL2023PLC412051. Listed on BSE: 544143.
Royal Sense reported revenue of ₹103.38 Cr for FY 2025-26 (up 67.5% YoY) based on consolidated financials.
Royal Sense has 5 current directors:
- Rishabh Arora - Managing Director
- Harmeet Singh - Whole-Time Director
- Kajal - Director
- Heena Soni - Director
- Vikas - Director
The latest financial statements of Royal Sense on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Royal Sense is L46491DL2023PLC412051. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Royal Sense is a listed company as per MCA records. Its shares are listed on BSE (code: 544143).
Royal Sense has 9 court cases on record: 9 filed by the company. 9 are pending.
Royal Sense was incorporated on 06 April 2023, making it 3+ years old. It is registered with the Registrar of Companies, Delhi.
Royal Sense has 9 deals on record (5 market trades, 2 secondary share transfers, 1 ipo), with disclosed funding of ₹3.44 Cr; the latest was in April 2024.
The peers of Royal Sense by revenue are Pioneer Medical Systems Private Limited, Medline Healthcare Industries Private Limited, Molnlycke Health Care India Private Limited, Satyam Synergy India Private Limited, Advanced Bionics India Private Limited and 2 more, all in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading).
Heena Soni ceased to be Additional Director on 22 Oct 2024. Kajal ceased to be Additional Director on 22 Oct 2024. Heena Soni was appointed as Director on 30 May 2024. Royal Sense has 16 board changes on record in total.